• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬认知功能障碍综合征血液诊断生物标志物的评估

Evaluation of Blood-Based Diagnostic Biomarkers for Canine Cognitive Dysfunction Syndrome.

作者信息

Yoon Jun-Won, Nam Chan-Sik, Lee Kwang-Sup, Dan Tae-Jung, Jeon Hee-Jung, Kang Mi-Ae, Park Hee-Myung

机构信息

Department of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea.

VET and GENE, Seongnam 13209, Republic of Korea.

出版信息

Animals (Basel). 2025 Jul 4;15(13):1974. doi: 10.3390/ani15131974.

DOI:10.3390/ani15131974
PMID:40646873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249050/
Abstract

Canine cognitive dysfunction syndrome (CDS) is a progressive neurodegenerative disorder in aging dogs and serves as a natural model for Alzheimer's disease in humans. This study evaluated blood biomarkers-amyloid-beta (Aβ40, Aβ42), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP)-for diagnosing and staging CDS and assessed whether combining biomarkers with behavioral questionnaires improves diagnostic reliability. Seventy-seven dogs, including healthy controls and CDS cases, were assessed using the Canine Cognitive Dysfunction Rating Scale (CCDR), Canine Dementia Scale (CADES), and Canine Cognitive Assessment Scale (CCAS). Plasma Aβ40, Aβ42, GFAP, and serum NfL levels were measured via ELISA. While Aβ40, Aβ42, and GFAP were not significantly associated with CDS stage, serum NfL levels were elevated ( < 0.05) across all questionnaires. Receiver operating characteristic (ROC) analyses showed areas under the curve (AUCs) of 0.763 (CCDR), 0.722 (CADES), and 0.777 (CCAS), with cut-off values around 18.28-43.13 pg/mL. NfL shows promise as a blood biomarker correlated with CDS severity. Combining serum NfL measurements with questionnaire assessments may enhance diagnostic accuracy for CDS in veterinary practice.

摘要

犬认知功能障碍综合征(CDS)是老年犬的一种进行性神经退行性疾病,可作为人类阿尔茨海默病的天然模型。本研究评估了血液生物标志物——淀粉样β蛋白(Aβ40、Aβ42)、神经丝轻链(NfL)和胶质纤维酸性蛋白(GFAP)——用于CDS的诊断和分期,并评估将生物标志物与行为问卷相结合是否能提高诊断可靠性。使用犬认知功能障碍评定量表(CCDR)、犬痴呆量表(CADES)和犬认知评估量表(CCAS)对77只犬进行评估,包括健康对照犬和CDS病例。通过酶联免疫吸附测定法测量血浆Aβ40、Aβ42、GFAP和血清NfL水平。虽然Aβ40、Aβ42和GFAP与CDS分期无显著相关性,但在所有问卷中血清NfL水平均升高(<0.05)。受试者工作特征(ROC)分析显示,曲线下面积(AUC)分别为0.763(CCDR)、0.722(CADES)和0.777(CCAS),截断值约为18.28 - 43.13 pg/mL。NfL有望作为与CDS严重程度相关的血液生物标志物。在兽医实践中,将血清NfL测量与问卷评估相结合可能会提高CDS的诊断准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/19d1abba4a63/animals-15-01974-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/477b6d7f2f36/animals-15-01974-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/2d568429eeed/animals-15-01974-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/46380462c3fe/animals-15-01974-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/a6c166bcc134/animals-15-01974-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/8b8d659bb444/animals-15-01974-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/0dc093848431/animals-15-01974-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/19d1abba4a63/animals-15-01974-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/477b6d7f2f36/animals-15-01974-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/2d568429eeed/animals-15-01974-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/46380462c3fe/animals-15-01974-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/a6c166bcc134/animals-15-01974-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/8b8d659bb444/animals-15-01974-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/0dc093848431/animals-15-01974-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f730/12249050/19d1abba4a63/animals-15-01974-g007.jpg

相似文献

1
Evaluation of Blood-Based Diagnostic Biomarkers for Canine Cognitive Dysfunction Syndrome.犬认知功能障碍综合征血液诊断生物标志物的评估
Animals (Basel). 2025 Jul 4;15(13):1974. doi: 10.3390/ani15131974.
2
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study.血浆Aβ42/40比值、磷酸化tau181、胶质纤维酸性蛋白(GFAP)和神经丝轻链(NfL)在阿尔茨海默病和非阿尔茨海默病性痴呆连续病程中的诊断性能:一项国际多中心研究
Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.
3
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
4
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.
5
Diagnostic dynamic contrast-enhanced magnetic resonance imaging blood-brain barrier assessment combined with plasma biomarkers for mild cognitive impairment.诊断性动态对比增强磁共振成像血脑屏障评估联合血浆生物标志物用于轻度认知障碍
World J Psychiatry. 2025 Jun 19;15(6):103661. doi: 10.5498/wjp.v15.i6.103661.
6
Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study.社区动脉粥样硬化风险研究中阿尔茨海默病和神经退行性变的嗅觉与血浆生物标志物
Neurology. 2025 Jun 10;104(11):e213706. doi: 10.1212/WNL.0000000000213706. Epub 2025 May 15.
7
Timing of changes in Alzheimer's disease plasma biomarkers as assessed by amyloid and tau PET clocks.通过淀粉样蛋白和tau PET时钟评估阿尔茨海默病血浆生物标志物变化的时间。
medRxiv. 2024 Nov 14:2024.10.25.24316144. doi: 10.1101/2024.10.25.24316144.
8
Kidney function is associated with plasma ATN biomarkers among Hispanics/Latinos: SOL-INCA and HCHS/SOL results.西班牙裔/拉丁裔人群的肾功能与血浆急性肾损伤生物标志物相关:SOL-INCA和HCHS/SOL研究结果
Alzheimers Res Ther. 2025 Jun 19;17(1):137. doi: 10.1186/s13195-025-01786-8.
9
Short-term variability of Alzheimer's disease plasma biomarkers in a mixed memory clinic cohort.混合记忆门诊队列中阿尔茨海默病血浆生物标志物的短期变异性
Alzheimers Res Ther. 2025 Jan 21;17(1):26. doi: 10.1186/s13195-024-01658-7.
10
Plasma NfL and GFAP for predicting VCI and related brain changes in community and clinical cohorts.血浆神经丝轻链蛋白(NfL)和胶质纤维酸性蛋白(GFAP)用于预测社区和临床队列中的血管性认知障碍(VCI)及相关脑改变。
Alzheimers Dement. 2025 Jun;21(6):e70381. doi: 10.1002/alz.70381.

引用本文的文献

1
Diagnosis of Canine Cognitive Dysfunction Syndrome: A Narrative Review.犬认知功能障碍综合征的诊断:一篇叙述性综述
Vet Sci. 2025 Aug 20;12(8):781. doi: 10.3390/vetsci12080781.

本文引用的文献

1
Comparing standard screening questionnaires of canine behavior for assessment of cognitive dysfunction.比较用于评估认知功能障碍的犬类行为标准筛查问卷。
Front Vet Sci. 2024 May 21;11:1374511. doi: 10.3389/fvets.2024.1374511. eCollection 2024.
2
Use of neurofilament light chain to identify structural brain diseases in dogs.使用神经丝轻链鉴定犬的结构性脑疾病。
J Vet Intern Med. 2024 Jul-Aug;38(4):2196-2203. doi: 10.1111/jvim.17110. Epub 2024 May 22.
3
Evaluation of neurofilament light chain as a biomarker in dogs with structural and idiopathic epilepsy.
评估神经丝轻链作为结构性和特发性癫痫犬的生物标志物。
J Vet Intern Med. 2024 May-Jun;38(3):1577-1582. doi: 10.1111/jvim.17033. Epub 2024 Mar 20.
4
Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome.血浆神经丝轻链作为犬认知功能障碍综合征早期诊断的血液生物标志物。
Int J Mol Sci. 2023 Sep 6;24(18):13771. doi: 10.3390/ijms241813771.
5
Evaluation of Two Practical Tools to Assess Cognitive Impairment in Aged Dogs.评估两种用于评估老年犬认知障碍的实用工具。
Animals (Basel). 2022 Dec 15;12(24):3538. doi: 10.3390/ani12243538.
6
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.血清胶质纤维酸性蛋白可区分阿尔茨海默病与额颞叶痴呆,并预测轻度认知障碍向痴呆的转化。
J Neurol Neurosurg Psychiatry. 2022 Apr 27. doi: 10.1136/jnnp-2021-328547.
7
Canine Cognitive Dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue.犬认知功能障碍(CCD)评分与狗脑组织中的淀粉样蛋白β 42 水平相关。
Geroscience. 2021 Oct;43(5):2379-2386. doi: 10.1007/s11357-021-00422-1. Epub 2021 Aug 20.
8
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.血浆 GFAP 是阿尔茨海默病中淀粉样-β但不是 tau 病理学的早期标志物。
Brain. 2021 Dec 16;144(11):3505-3516. doi: 10.1093/brain/awab223.
9
Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs.神经丝轻链作为犬不明病因脑膜脑炎的生物标志物。
J Vet Intern Med. 2021 Jul;35(4):1865-1872. doi: 10.1111/jvim.16184. Epub 2021 Jun 10.
10
How Old Is My Dog? Identification of Rational Age Groupings in Pet Dogs Based Upon Normative Age-Linked Processes.我的狗多大了?基于与年龄相关的正常生理过程确定宠物狗的合理年龄分组。
Front Vet Sci. 2021 Apr 27;8:643085. doi: 10.3389/fvets.2021.643085. eCollection 2021.